Sentences with phrase «for ovarian cancer research»

The study was also funded by the National Cancer Institute (R01CA142776, P50CA083638), the Ovarian Cancer Research Fund, the Breast Cancer Alliance, the Department of Defense, the Marsha Rivkin Center for Ovarian Cancer Research, and the China Scholarship Council.

Ultimately, I decided to use my graphic design skills to celebrate Sarah's impeccable style while raising funds for ovarian cancer research — the result being these chic, cheerful, and eco-friendly Hello, Gorgeous greeting cards.

The company is gaining national attention for its accelerated growth and commitment to community, including Newk's Cares, an ongoing program which has raised more than $ 720,000 for ovarian cancer research and awareness.

Not exact matches

Electrolux and Kelly Ripa are proud to support the Ovarian Cancer Research Fund whose mission is to fund research to find a method of early detection and ultimately a cure for OvarianResearch Fund whose mission is to fund research to find a method of early detection and ultimately a cure for Ovarianresearch to find a method of early detection and ultimately a cure for Ovarian Cancer.

For every vote, Electrolux is donating $ 1 to the Ovarian Cancer Research Fund.

Research indicates that breastfeeding is beneficial for both you and your baby — you experience lower risk of ovarian cancer, postpartum depression, breast cancer and diabetes, while your baby receives all the good nutrients and also has a lower risk of diseases like diabetes, obesity, asthma and lower respiratory infections.

Reams of research have linked breastfeeding to scores of benefits for both mom and baby: breast - fed babies aren't as likely to fall prey to obesity, ear infections or diabetes; breast - feeding moms benefit from a decreased risk of breast and ovarian cancer.

Scientists at Lawson Health Research Institute have uncovered an important new target for ovarian cancer therapy.

Funding for the study was provided by the National Institutes of Health (P50 CA083638, R21 CA156224, 5P30 CA016520 - 36), the Marcus Foundation, the Ovarian Cancer Immunotherapy Initiative, the Ludwig Institute for Cancer Research at the University of Lausanne, and the Ovacure Foundation.

«While the presence of lymphocytes in tumors is often associated with better clinical outcomes, this research adds clarity on the diversity of T cells within the tumor environment and their influence on ovarian cancer outcomes,» says first author Kunle Odunsi, MD, PhD, FRCOG, FACOG, Deputy Director, M. Steven Piver Professor and Chair of Gynecologic Oncology, and Executive Director of the Center for Immunotherapy at Roswell Park.

«However, additional research is needed to further evaluate the therapy for this type of ovarian cancer.»

Cancer researcher Janet Sawicki of the Lankenau Institute for Medical Research in Pennsylvania, chemical engineer Robert Langer of MIT, and their colleagues are investigating biodegradable nanoparticles to deliver gene therapy for ovarian cCancer researcher Janet Sawicki of the Lankenau Institute for Medical Research in Pennsylvania, chemical engineer Robert Langer of MIT, and their colleagues are investigating biodegradable nanoparticles to deliver gene therapy for ovarian cancercancer.

Researchers using data collected by the Ovarian Cancer Association Consortium have discovered uncommon variants in new regions of the genome that influence ovarian cancer risk, and will present their findings on April 6, 2014 at the American Association for Cancer Research Annual Meeting in San DieOvarian Cancer Association Consortium have discovered uncommon variants in new regions of the genome that influence ovarian cancer risk, and will present their findings on April 6, 2014 at the American Association for Cancer Research Annual Meeting in San DiegCancer Association Consortium have discovered uncommon variants in new regions of the genome that influence ovarian cancer risk, and will present their findings on April 6, 2014 at the American Association for Cancer Research Annual Meeting in San Dieovarian cancer risk, and will present their findings on April 6, 2014 at the American Association for Cancer Research Annual Meeting in San Diegcancer risk, and will present their findings on April 6, 2014 at the American Association for Cancer Research Annual Meeting in San DiegCancer Research Annual Meeting in San Diego, CA.

Acknowledging that «this is not a big study, in terms of the overall number of cases, for ovarian cancer it's a very big study,» explains Annekatrin Lukanova of the International Agency for Cancer Research in Lyon, Fcancer it's a very big study,» explains Annekatrin Lukanova of the International Agency for Cancer Research in Lyon, FCancer Research in Lyon, France.

Supported by the Basser Research Center for BRCA in Penn's Abramson Cancer Center, Zhang and his team built a DNA copy number profile for nearly 14,000 long non-coding RNA, or lncRNAs, across 12 cancer types, including ovarian and breast cancers — the two major BRCA - related caCancer Center, Zhang and his team built a DNA copy number profile for nearly 14,000 long non-coding RNA, or lncRNAs, across 12 cancer types, including ovarian and breast cancers — the two major BRCA - related cacancer types, including ovarian and breast cancers — the two major BRCA - related cancers.

The lab of co-author Dr. Robert Bast Jr., an expert in ovarian cancer and vice president for translational research at MD Anderson, inserted gel - bound carbon nanotubes into the ovaries of rodents to mimic the accumulations that are expected for nanotubes linked to special antibodies that recognize tumor cells.

Professor Peter Johnson, Cancer Research UK's chief clinician, said: «Although we're making great progress, we still have more to do for people with ovarian cancer, as only one in three patients survive for 10 years or lCancer Research UK's chief clinician, said: «Although we're making great progress, we still have more to do for people with ovarian cancer, as only one in three patients survive for 10 years or lcancer, as only one in three patients survive for 10 years or longer.

«Ovarian removal to prevent ovarian cancer should not be an option for premenopausal women, research finds.Ovarian removal to prevent ovarian cancer should not be an option for premenopausal women, research finds.ovarian cancer should not be an option for premenopausal women, research finds.»

Technology developed at Western University and Lawson Health Research Institute can provide a new window into whether or not patients are responding to treatment for advanced ovarian cancer.

Dr. Narod, who is also a Tier 1 Canada Research Chair in Breast Cancer, recommends that doctors should consider adopting a standard model of care for all women diagnosed with advanced - stage ovarian cCancer, recommends that doctors should consider adopting a standard model of care for all women diagnosed with advanced - stage ovarian cancercancer:

Up to half of women with advanced - stage ovarian cancer might be cured, compared to the current 20 per cent survival rate, argues Dr. Steven Narod, senior scientist at Women's College Research Institute, who calls for a new standard of treatment for women with late - stage ovarian cancer.

«There is currently no national screening programme for ovarian cancer, as research to date has been unable to provide enough evidence that any one method would improve early detection of tumours.

«For decades, women have been treated with a combination of treatment options, resulting in poor prognosis for most women with advanced - stage ovarian cancer, but there are many survivors as well,» said Dr. Narod, senior scientist at Women's College Research InstituFor decades, women have been treated with a combination of treatment options, resulting in poor prognosis for most women with advanced - stage ovarian cancer, but there are many survivors as well,» said Dr. Narod, senior scientist at Women's College Research Institufor most women with advanced - stage ovarian cancer, but there are many survivors as well,» said Dr. Narod, senior scientist at Women's College Research Institute.

«What we did in this paper is engineer our sensor to be about 15 times better than a previous version, and then compared it against a blood biomarker in a mouse model of ovarian cancer to show that we could beat it,» says Sangeeta Bhatia, the John and Dorothy Wilson Professor of Health Sciences and Technology and Electrical Engineering and Computer Science, a member of MIT's Koch Institute for Integrative Cancer Research and Institute for Medical Engineering and Science, and the senior author of the cancer to show that we could beat it,» says Sangeeta Bhatia, the John and Dorothy Wilson Professor of Health Sciences and Technology and Electrical Engineering and Computer Science, a member of MIT's Koch Institute for Integrative Cancer Research and Institute for Medical Engineering and Science, and the senior author of the Cancer Research and Institute for Medical Engineering and Science, and the senior author of the study.

«Scientists track ovarian cancers to site of origin: Fallopian tubes: Small study offers proof of concept, support for wider research.»

Olaparib was licensed in December for women with ovarian cancer and inherited BRCA mutations, but the new research suggests it could also benefit men with genomic faults within their tumours.

The research, «Synchrotron X-Ray Fluorescence Nanoprobe Reveals Target Sites for Organo - Osmium Complex in Human Ovarian Cancer Cells», is published in Chemistry — A European Journal.

Longer term, they want to quickly diagnose additional cancer types, including ovarian and pancreatic cancers, which are fast - spreading and require early detection for a patient to survive, says Goda, who was recently appointed as a chemistry professor at the University of Tokyo but will continue his research with U.C.L.A..

Led by Ludwig Lausanne investigator Alexandre Harari and George Coukos, director of the Ludwig Institute for Cancer Research, Lausanne, the study shows that ovarian tumors harbor highly reactive killer T cells — which kill infected and cancerous cells — and demonstrates how they can be identified and selectively grown for use in personalized, cell - based immunotherapies.

I was honored to receive the Mentor Award from the American Congress of Obstetricians and Gynecologists in 2012 and the Foundation for Women's Cancer's Excellence in Ovarian Cancer Research Prize in 2013.

My research has been supported by the National Cancer Institute, the Department of Defense, Stand Up to Cancer, the Ovarian Cancer Research Fund, the Foundation for Women's Cancer, the Entertainment Industry Foundation, and Cycle for Sresearch has been supported by the National Cancer Institute, the Department of Defense, Stand Up to Cancer, the Ovarian Cancer Research Fund, the Foundation for Women's Cancer, the Entertainment Industry Foundation, and Cycle for SResearch Fund, the Foundation for Women's Cancer, the Entertainment Industry Foundation, and Cycle for Survival.

Rieger conducted her research in zebrafish exposed to paclitaxel, a chemotherapeutic agent used for ovarian, breast, lung, pancreatic and other cancers.

After years of breaking ground on nanomaterials for batteries and solar panels, in 2010 she joined MIT's Koch Institute for Integrative Cancer Research and threw herself into solving the riddles of ovarian cCancer Research and threw herself into solving the riddles of ovarian cancercancer.

The research evidence on breast, colorectal (bowel), pancreatic, endometrial (womb), ovarian, prostate, liver, gallbladder, kidney, bladder, stomach and oesophageal cancers has been updated as part of our Continuous Update Project (CUP); these CUP reports replace the conclusions for these cancers from the Second Expert Report.

Since 1985, CRI has made more than 75 grants totaling more than $ 21 million in new research and treatment approaches for ovarian cancer.

He is the principal investigator of an NCI - funded, multi-million-dollar Specialized Program of Research Excellence (SPORE) in ovarian cancer, and he is the principal investigator of a multi-million-dollar grant from the New York State Stem Cell Science program (NYSTEM) to pioneer a novel strategy of reprogramming human mature T cells and hematopoietic stem cells for generating sustained attack against ovarian cancer in patients.

A research team led by an award - winning genomicist at Western University has developed a new method for identifying mutations and prioritizing variants in breast and ovarian cancer genes, which will not only reduce the number of possible variants for doctors to investigate, but also increase the number of patients that are properly diagnosed.

An ovarian cancer drug can leak through the blood brain barrier to reach brain tumours and could be an effective treatment for glioblastoma, suggest results presented at the National Cancer Research Institute's (NCRI) Cancer Conference in Liverpool, today (Mocancer drug can leak through the blood brain barrier to reach brain tumours and could be an effective treatment for glioblastoma, suggest results presented at the National Cancer Research Institute's (NCRI) Cancer Conference in Liverpool, today (MoCancer Research Institute's (NCRI) Cancer Conference in Liverpool, today (MoCancer Conference in Liverpool, today (Monday).

Rogan, Canada Research Chair in Genome Bioinformatics, says that 16 to 20 per cent of women in southwestern Ontario, who have their BRCA genes tested for breast and / or ovarian cancer risk, carry disease - causing gene variants that are well - understood by clinicians and genetic counselors.

The research presentations cover a wide range of disciplines, treatment approaches and cancer types, including a unique form of immunotherapy for ovarian cancer, promising results on a new treatment approach for Hodgkin lymphoma in children and young adults and an effort to build a predictive tool to determine which patients are most likely to respond well to checkpoint inhibitors.

Offit says that in his clinic, where the panel is already being used in research studies, he was able to test the daughter of a man with metastatic prostate cancer and learn that she carried mutations that put her at higher risk for ovarian cancer.

A 2013 research review published in Obstetrics and Gynecology examined the results of 55 studies and found that for women with average risk, using oral contraceptives reduced lifetime risk of ovarian cancer by 40 to 50 %.

Besides its recommendation on who should or should not be screened, the task force «is calling for research to find better screening tests and treatments that can help reduce the number of women who die from ovarian cancer,» said task force member Dr. Chien - Wen Tseng.

THURSDAY, Jan. 18, 2018 (HealthDay News)-- It's known that use of the birth control pill is tied to lower odds for ovarian cancer, but new research shows the benefit extends to smokers or women who are obese.

Julianne Hough, Chloë Grace Moretz, Nikki Reed, Brooklyn Decker, and AnnaSophia Robb all helped fashion styles for the collection, with proceeds benefitting ovarian cancer research.

If you needed another reason to keep rose days going, for every bottle of the #DrinkPink wine collections that is sold, ONEHOPE is donating to The Ovarian Cancer Research Fund Alliance and / or the Gateway for Cancer Research.

It follows the journey of English Literature professor and specialist of John Donne, Vivian Bearing, as she discovers that she has stage four ovarian cancer and undergoes radical treatment, in part for the sake of research.

After years of painstaking research, she discovered the BRCA1 gene, the inherited mutation that indicates an elevated risk for breast and ovarian cancer, proving that such cancers are passed down from generation to generation.

In an interdisciplinary collaboration, the University of Pennsylvania School of Veterinary Medicine's Working Dog Center (photo above courtesy of University of Pennsylvania), the School of Arts and Science's Department of Physics and Astronomy, Penn Medicine's Division of Gynecologic Oncology, and the Monell Chemical Senses Center have joined together for a research investigation using canine olfaction, along with chemical and nanotechnology analysis, to detect early - stage human ovarian cancer.

SCOTTSDALE, Ariz. — Sept. 8, 2015 — Sanctuary on Camelback Mountain — renowned as a gathering point for the country's most seasoned spa healers — has launched a Spa for a Dream promotion benefitting Colleen's Dream Foundation, an Arizona - based organization that funds ovarian cancer research.